The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been endorsed by the ANZCTR. Before participating in a study, talk to your health care provider and refer to this information for consumers
Trial registered on ANZCTR


Registration number
Help: Registration number
ACTRN12626000890336
Ethics application status
Help: Ethics application status
Approved
Date submitted
Help: Date submitted
21/06/2026
Date registered
Help: Date registered
20/07/2026
Date last updated
Help: Date last updated
20/07/2026
Date data sharing statement initially provided
Help: Data sharing statement date
20/07/2026
Type of registration
Help: Type of registration
Prospectively registered

Titles & IDs
Public title
The Chronic Conditions Course for Young Adults (CCC-YA): An evaluation of an adapted online psychological program for young adults with chronic physical health conditions
Scientific title
Examining the efficacy and acceptability of an adapted online psychological program for young adults with chronic physical health conditions
Additional trial identifiers [1] 317563 0
None
Universal Trial Number (UTN)
Trial acronym
Related trial records

Health condition
Health condition(s) studied:
Various chronic physical health conditions/diseases 342424 0
Anxiety 342425 0
Depression 342430 0
Diabetes 342900 0
Chronic pain 342901 0
Arthritis and other musculoskeletal conditions 342902 0
Inflammatory bowel disease 342903 0
Asthma 342904 0
Migraine 342905 0
Endometriosis 342906 0
PCOS 342907 0
Condition category
Condition code
Mental Health 338559 338559 0 0
Anxiety
Mental Health 338560 338560 0 0
Depression
Musculoskeletal 338564 338564 0 0
Other muscular and skeletal disorders
Oral and Gastrointestinal 338565 338565 0 0
Inflammatory bowel disease
Metabolic and Endocrine 338566 338566 0 0
Diabetes
Reproductive Health and Childbirth 338568 338568 0 0
Other reproductive health and childbirth disorders
Cardiovascular 338569 338569 0 0
Other cardiovascular diseases
Inflammatory and Immune System 338570 338570 0 0
Autoimmune diseases
Respiratory 338571 338571 0 0
Asthma

Intervention/exposure
Study type
Interventional
Description of the intervention or exposure
The intervention, the Chronic Conditions Course for Young Adults, is an internet-delivered self-management program. It is adapted from the Chronic Conditions Course for young adults aged 18-29 with chronic physical health conditions. The program is based on cognitive behaviour therapy (CBT) principles and teaches evidence-based skills for managing the impacts of chronic health conditions on daily functioning and emotional wellbeing. Adaptations from the original program include developmentally tailored language, case stories and examples, modifications to content delivery and format, and the inclusion of additional material targeting key domains relevant to young adulthood (e.g., study, work, relationships, identity, and independence).

The course runs for 8 weeks and consists of:
(a) 5 online lessons with exercises for learning the information and skills. The duration of each lesson is approximately 20 to 30 minutes. Lessons can be viewed in the online platform, or downloaded as PDF files. Lessons are accompanied by lesson worksheets which can be downloaded and/or printed as PDF files. Participants are encouraged to engage with the home-based exercises at a frequency and duration that is helpful for them, though a suggested time commitment of at least 30 minutes each week is encouraged. The first lesson (week 1) provides an introduction and overview of the course, including psychoeducation about chronic health conditions and emotional wellbeing, tailored to the experiences and developmental context of young adults. Participants are encouraged to identify their symptoms (e.g., thinking styles, physical symptoms, unhelpful habits) as a home-based exercise. Lesson 2 (week 2) introduces cognitive challenging skills, and participants are encouraged to practise thought challenging in the following two weeks. Lesson 3 (week 4) covers behavioural activation and relaxation strategies to manage mood and anxiety symptoms, and participants are provided with resources to undertake activity scheduling as a home-based task. Lesson 4 (week 5) introduces activity pacing to manage symptoms such as pain and fatigue, and graded exposure to manage anxiety and avoidance. Following lesson 4, participants are encouraged to attempt activity pacing and/or graded exposure tasks as a home-based exercise. Lesson 5 (week 7) includes information and strategies relating to relapse prevention, and participants are given materials to help with goal-setting for the future and a relapse prevention plan.

(b) Automatic emails that help guide people through the course, sent once or twice per week. Examples of these e-mails include: reminders when new lessons are available, congratulatory messages once a lesson has been completed, brief messages that reinforce the core concepts of the lessons, and e-mails inviting contact and encouraging engagement if a participant has not logged in for a while.

(c) Additional Resources developed specifically for this study. These resources provide information about different problems people often struggle with, including managing sleep, working with health professionals, etc.

(d) Case stories and examples based on previous participants, tailored to reflect the experiences of young adults with chronic health conditions. These are briefly incorporated into each lesson and available as optional materials that participants can access at their own discretion.

Participants will have the option of support from a psychologist as they work through the course, via telephone or secure personal messaging. All psychologists will be nationally registered and employed by Macquarie University. All psychologists will be provided with training and supervision from a senior psychologist to ensure competence and safety in their practice.

Adherence with the intervention is monitored via the study's secure web platform, which records the number of participant log-ins, lesson completions, time spent completing each lesson, and number of downloads of additional resources.
Intervention code [1] 334479 0
Behaviour
Intervention code [2] 334480 0
Treatment: Other
Description of the comparator or control
A matched historical comparison group will be derived from de-identified data from young adults aged 18-29 who previously received the original Chronic Conditions Course as part of two prior randomised controlled trials. This comparison group will not receive any additional intervention as part of the current trial.

Trial 1: ACTRN12616001214426. Data collection period: 26/09/2016 to 01/07/2020.
Trial 2: ACTRN12620000969965. Data collection period: 12/10/2020 to 01/07/2025.
Control group
Historical

Outcomes
Primary outcome [1] 345851 0
Depression
Timepoint [1] 345851 0
Application, pre-treatment, post-treatment (9-weeks post intervention commencement - primary endpoint), 3-months post-treatment commencement.
Primary outcome [2] 345852 0
Anxiety
Timepoint [2] 345852 0
Application, pre-treatment, post-treatment (9-weeks post intervention commencement - primary endpoint), 3-months post-treatment commencement.
Primary outcome [3] 345853 0
Disability
Timepoint [3] 345853 0
Application, pre-treatment, mid-treatment (4 weeks post-treatment commencement), post-treatment (9-weeks post intervention commencement - primary endpoint), 3-months post-treatment commencement.
Secondary outcome [1] 463505 0
Health-related Quality of Life
Timepoint [1] 463505 0
Pre-treatment, post-treatment, 3-months post-treatment commencement.
Secondary outcome [2] 463506 0
Daily Functioning
Timepoint [2] 463506 0
Pre-treatment, post-treatment, 3-months post-treatment commencement.
Secondary outcome [3] 463507 0
Pain Intensity
Timepoint [3] 463507 0
Pre-treatment, post-treatment, 3-months post-treatment commencement.
Secondary outcome [4] 463508 0
Fatigue Severity
Timepoint [4] 463508 0
Pre-treatment, post-treatment, 3-months post-treatment commencement.
Secondary outcome [5] 463509 0
Symptom Severity
Timepoint [5] 463509 0
Pre-treatment, post-treatment, 3-months post-treatment commencement.
Secondary outcome [6] 463510 0
Chronic Disease Self-Efficacy
Timepoint [6] 463510 0
Pre-treatment, post-treatment, 3-months post-treatment commencement.
Secondary outcome [7] 463511 0
Satisfaction with participation in social roles and activities
Timepoint [7] 463511 0
Pre-treatment, post-treatment, 3-months post-treatment commencement.
Secondary outcome [8] 463512 0
Anxiety
Timepoint [8] 463512 0
Mid-treatment (4-weeks post intervention commencement)
Secondary outcome [9] 463513 0
Depression
Timepoint [9] 463513 0
Mid-treatment (4-weeks post intervention commencement)
Secondary outcome [10] 463514 0
Treatment Satisfaction
Timepoint [10] 463514 0
Post-treatment
Secondary outcome [11] 463515 0
Illness Intrusiveness
Timepoint [11] 463515 0
Pre-treatment, post-treatment, 3-months post-treatment commencement.
Secondary outcome [12] 465261 0
Chronic Illness Acceptance
Timepoint [12] 465261 0
Pre-treatment, post-treatment, 3-months post-treatment commencement.

Eligibility
Key inclusion criteria
a) Diagnosed with a chronic physical health condition
b) Self-reported impact of chronic health condition on mental health
c) Aged 18-29 years
d) English speaking
e) Living in Australia
Minimum age
18 Years
Maximum age
29 Years
Sex
Both males and females
Healthy volunteers
No
Key exclusion criteria
(a) Imminent risk of suicide or unable to keep themselves safe
b) Physical chronic illness not currently managed by a medical professional
c) Does not have access to a computer/tablet and the internet

Study design
Purpose of the study
Treatment
Allocation to intervention
Non-randomised trial
Procedure for enrolling a subject and allocating the treatment (allocation concealment procedures)
Methods used to generate the sequence in which subjects will be randomised (sequence generation)
Masking / blinding
Open (masking not used)
Who is / are masked / blinded?



Intervention assignment
Single group
Other design features
Phase
Not Applicable
Type of endpoint/s
Efficacy
Statistical methods / analysis
With a two-sided alpha of 0.05 and power of 0.80, a minimum sample of N = 83 participants in the CCC-YA group will provide adequate power to detect a moderate effect size (Cohen's d = 0.40) for the primary between-group comparison with the available matched historical controls (n = 125). This sample size is also sufficient to detect a within-group pre-post effect of the same size for the primary outcome. To account for attrition, we will aim to recruit N = 100 participants.

All analyses will be carried out using intention-to-treat principles, with multiple imputation used to handle missing data. Analyses will be conducted to (i) evaluate change in outcomes over time for participants receiving the adapted intervention (CCC-YA), and (ii) estimate comparative effects with a matched historical group who received the original Chronic Conditions Course.

Primary outcomes will be analysed using mixed-effects models with random subject effect, and fixed effects for group (adapted vs. original), time (pre-treatment, post-treatment, 3-month follow-up), and group by time interaction to test whether change over time differs between groups. Interaction contrasts will be used to examine treatment effects. The same modelling approach will be used to examine within-group change in secondary outcomes over time.

Recruitment
Recruitment status
Not yet recruiting
Date of first participant enrolment
Anticipated
Actual
Date of last participant enrolment
Anticipated
Actual
Date of last data collection
Anticipated
Actual
Sample size
Target
Accrual to date
Final
Recruitment in Australia
Recruitment state(s)
ACT,NSW,NT,QLD,SA,TAS,WA,VIC

Funding & Sponsors
Funding source category [1] 322120 0
University
Name [1] 322120 0
Macquarie University
Country [1] 322120 0
Australia
Primary sponsor type
University
Name
Macquarie University
Address
Country
Australia
Secondary sponsor category [1] 325013 0
None
Name [1] 325013 0
Address [1] 325013 0
Country [1] 325013 0

Ethics approval
Ethics application status
Approved
Ethics committee name [1] 320650 0
Macquarie University Human Research Ethics Committee Medical Sciences
Ethics committee address [1] 320650 0
Ethics committee country [1] 320650 0
Australia
Date submitted for ethics approval [1] 320650 0
22/03/2026
Approval date [1] 320650 0
29/05/2026
Ethics approval number [1] 320650 0
520262059168198

Summary
Brief summary
Trial website
Trial related presentations / publications
Public notes

Contacts
Principal investigator
Name 151170 0
Prof Blake Dear
Address 151170 0
School of Psychological Sciences, 16 University Avenue, Macquarie University NSW 2109
Country 151170 0
Australia
Phone 151170 0
+61 2 9850 9979
Fax 151170 0
Email 151170 0
Contact person for public queries
Name 151171 0
Nicole Harte
Address 151171 0
Department of Psychology Macquarie University Balaclava Road Macquarie Park NSW 2109
Country 151171 0
Australia
Phone 151171 0
+61 2 9850 9464
Fax 151171 0
Email 151171 0
Contact person for scientific queries
Name 151172 0
Nicole Harte
Address 151172 0
Department of Psychology Macquarie University Balaclava Road Macquarie Park NSW 2109
Country 151172 0
Australia
Phone 151172 0
+61 2 9850 9464
Fax 151172 0
Email 151172 0

Data sharing statement
Will the study consider sharing individual participant data?
Yes
Will there be any conditions when requesting access to individual participant data?
Persons/groups eligible to request access:
• Researchers working with the approval and under the governance of a Human Research Ethics Committee.

Conditions for requesting access:
• Yes, conditions apply:
• Requires review on a case-by-case basis by the trial custodian, sponsor or data sharing committee
• Requires a scientifically sound proposal or protocol
• Requires approval by an ethics committee
• Requires a data sharing agreement between data requester and trial custodian or sponsor
What individual participant data might be shared?
• Any non-identifiable data necessary to verify the outcomes reported in any published reports by the research team.

What types of analyses could be done with individual participant data?
• Any analyses required to verify the outcomes reported in published reports.

When can requests for individual participant data be made (start and end dates)?
From:
After publication of main results
To:
No end date
Where can requests to access individual participant data be made, or data be obtained directly?
• Email of trial custodian, sponsor or committee: Data will be made available following formal request to the chief investigator using a mechanism that is satisfactory for the Macquarie University Human Research Ethics Committee (providing governance for the current research) and any other Human Research Ethics Committee's involved. Data can be obtained by e-mailing the chief investigator ([email protected])


Are there extra considerations when requesting access to individual participant data?
No


What supporting documents are/will be available?

No Supporting Document Provided


Results publications and other study-related documents

Documents added manually
No documents have been uploaded by study researchers.

Documents added automatically
No additional documents have been identified.